HealthcareServices

Bacterial Vaginosis Market Trends and Insights: Global Forecast to 2030

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the bacterial vaginosis market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Bacterial Vaginosis Market’s size between 2026 and 2030?

The bacterial vaginosis market has experienced substantial expansion in recent years. It is anticipated to expand from $3.31 billion in 2025 to $3.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. The growth observed in prior periods can be attributed to several factors, including the increasing occurrence of bacterial vaginosis among women, improved access to gynecological healthcare services, the availability of both oral and topical antibiotics, the proliferation of diagnostic laboratory services, and a rise in clinical screening programs.

The bacterial vaginosis market is anticipated to exhibit robust growth over the next few years, reaching a valuation of $5.13 billion by 2030, propelled by a compound annual growth rate (CAGR) of 9.1%. This expansion during the forecast period can be attributed to several factors, including the increasing development of microbiome-based therapies, the growing adoption of rapid molecular diagnostics, a rising focus on preventive women’s health, the expansion of telehealth-supported diagnosis, and increasing investment in non-antibiotic treatment alternatives. Furthermore, significant trends expected in this period encompass the increasing uptake of point-of-care diagnostic tests, a rising demand for targeted antibiotic therapies, growing awareness surrounding vaginal microbiome health, the proliferation of home-based testing solutions, and an enhanced focus on early detection and screening.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21110&type=smp

Which Drivers Are Shaping Strategic Decisions In The Bacterial Vaginosis Market?

The rising occurrence of sexually transmitted infections (STIs) is projected to propel the expansion of the bacterial vaginosis market in the future. STIs are defined as infections predominantly transmitted via sexual contact, and they can originate from bacteria, viruses, or parasites. This growing incidence of STIs is attributable to factors like unprotected sexual activity, having multiple partners, insufficient public awareness, and antibiotic resistance. Bacterial vaginosis heightens vulnerability to STIs by upsetting the natural balance of vaginal bacteria, thereby facilitating the establishment of infections such as HIV and chlamydia. For example, data from the European Centre for Disease Prevention and Control (ECDC), a government agency based in Sweden, indicates a significant increase in gonorrhea cases, climbing from 70,881 in 2022 (representing 17.9 per 100,000) to 96,969 in 2023 (or 25.0 per 100,000), marking a 31% year-on-year surge. Concurrently, reported syphilis cases ascended from 35,391 in 2022 (8.5 per 100,000) to 41,051 in 2023 (9.9 per 100,000), reflecting a 13% increase. Furthermore, chlamydia notifications totaled 230,199 in 2023, showing a 3% rise in the crude notification rate when compared to the previous year, 2022. Consequently, the rising frequency of sexually transmitted infections (STIs) is fueling the expansion of the bacterial vaginosis market.

What Segment Categories Are Covered In The Bacterial Vaginosis Market?

The bacterial vaginosis market covered in this report is segmented –

1) By Type: Point-Of-Care Testing, Laboratory Testing

2) By Application: Diagnosis, Treatment, Recurrence Prevention Or Maintenance, Screening And Monitoring

3) By End-User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Point-Of-Care Testing: Rapid Diagnostic Tests, Microscopy-based Tests

2) By Laboratory Testing: Gram Staining, Polymerase Chain Reaction (PCR), DNA Probe Tests

Which Trends Are Influencing The Development Of The Bacterial Vaginosis Market?

Leading firms within the bacterial vaginosis market are concentrating on creating novel solutions, including paired prescription regimens intended for sexual partners, as a means to achieve a competitive edge. Such regimens entail administering treatment to both the infected person and their sexual partner, thereby tackling the risk of recurrence directly at its origin. An example of this is Wisp, a U.S.-based women’s telehealth company, which introduced the pioneering Male BV Partner Treatment in March 2025. This treatment is a two-part prescription regimen, consisting of oral metronidazole and topical clindamycin, specifically for male partners. The regimen offers synchronized dual treatment, requires once-daily administration for seven days, and is delivered through Wisp’s telemedicine platform. This approach capitalizes on new clinical data to lower reinfection rates and supports a move towards more thorough, relationship-focused care. However, it could potentially heighten regulatory complexity and prompt issues regarding partner adherence.

Which Major Firms Are Strengthening Their Position In The Bacterial Vaginosis Market?

Major companies operating in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Viatris Inc., Organon & Co., Shionogi & Company Limited, Otsuka Pharmaceutical Co. Ltd., Melinta Therapeutics Inc., Evofem Biosciences Inc., Gedea Biotech AB, Hologic Inc., bioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Roche Holding AG, Abbott Laboratories, Ferring Pharmaceuticals, Mylan N.V., Almirall S.A.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Bacterial Vaginosis Market?

North America was the largest region in the bacterial vaginosis market in 2025. The regions covered in the bacterial vaginosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Bacterial Vaginosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21110&type=smp

Browse Through More Reports Similar to the Global Bacterial Vaginosis Market 2026, By The Business Research Company

Vaginal Speculum Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaginal-speculum-global-market-report

Bactericide Market Report 2026

https://www.thebusinessresearchcompany.com/report/bactericide-global-market-report

Acute Bacterial Skin And Skin Structure Infections Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-bacterial-skin-and-skin-structure-infections-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795